GSK sells thrombosis drugs to Aspen for $1 bn

Sep 30, 2013, 08.23 PM IST

The company said on Monday the divestment to South Africa's biggest generic drug maker would earn it proceeds of 600 million pounds and 100 million pounds of the headline price related to inventory.

Like this story, share it with millions of investors on M3

GSK sells thrombosis drugs to Aspen for $1 bn

The company said on Monday the divestment to South Africa's biggest generic drug maker would earn it proceeds of 600 million pounds and 100 million pounds of the headline price related to inventory.

Like this story, share it with millions of investors on M3

GSK sells thrombosis drugs to Aspen for $1 bn

The company said on Monday the divestment to South Africa's biggest generic drug maker would earn it proceeds of 600 million pounds and 100 million pounds of the headline price related to inventory.

Share  .  Email  .  Print  .  A+A-

Britain's biggest drugmaker GlaxoSmithKline agreed the 700 million pounds sale of its thrombosis drug brands and a related factory to Aspen Pharmacare

Action in GlaxoSmithKline Pharmaceuticals

Anda sedang membaca artikel tentang

GSK sells thrombosis drugs to Aspen for $1 bn

Dengan url

https://gayafashionshow.blogspot.com/2013/09/gsk-sells-thrombosis-drugs-to-aspen-for.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

GSK sells thrombosis drugs to Aspen for $1 bn

namun jangan lupa untuk meletakkan link

GSK sells thrombosis drugs to Aspen for $1 bn

sebagai sumbernya